Antonio Frena

Dr. Antonio Frena

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2020 in Cancers
Verified
Journal Article
Open access
PDF file
AGAlessandro Giani
Alessandro Giani
FCFederica Cipriani
Federica Cipriani
SFSimone Famularo
Simone Famularo
Matteo DonadonMatteo Donadon
Matteo Donadon
DBDavide P. Bernasconi
Davide P. Bernasconi
LGLuca Gianotti
Luca Gianotti
Background: We aimed to assess the ability of comprehensive complication index (CCI) and Clavien-Dindo complication (CDC) scale to predict excessive length of hospital stay (e-LOS) in patients undergoing liver resection for hepatocellular carcinoma. Methods: Patients were identified from an Italian multi-institutional database and randomly selected to be included in either a derivation or validation set. Multivariate logistic regression models and ROC curve analysis including either CCI or CDC as predictors of e-LOS were fitted to compare predictive performance. E-LOS was defined as a LOS longer than the 75th percentile among patients with at least one complication. Results: A total of 2669 patients were analyzed (1345 for derivation and 1324 for validation). The odds ratio (OR) was 5.590 (95%CI 4.201; 7.438) for CCI and 5.507 (4.152; 7.304) for CDC. The AUC was 0.964 for CCI and 0.893 for CDC in the derivation set and 0.962 vs. 0.890 in the validation set, respectively. In patients with at least two complications, the OR was 2.793 (1.896; 4.115) for CCI and 2.439 (1.666; 3.570) for CDC with an AUC of 0.850 and 0.673, respectively in the derivation cohort. The AUC was 0.806 for CCI and 0.658 for CDC in the validation set. Conclusions: When reporting postoperative morbidity in liver surgery, CCI is a preferable scale.

15 November 2024 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
SFSimone Famularo
Simone Famularo
CMCesare Maino
Cesare Maino
FMFlavio Milana
Flavio Milana
Francesco ArditoFrancesco Ardito
Francesco Ardito
GRGianluca Rompianesi
Gianluca Rompianesi
GTGuido Torzilli
Guido Torzilli

28 February 2022 in HPB
Verified
Journal Article
Closed access
SFSimone Famularo
Simone Famularo
NRNadia Russolillo
Nadia Russolillo
Matteo DonadonMatteo Donadon
Matteo Donadon
FCFederica Cipriani
Federica Cipriani
Francesco ArditoFrancesco Ardito
Francesco Ardito
DGDavide Gaudesi
Davide Gaudesi

15 January 2025 in World Journal of Gastrointestinal Oncology
Verified
Journal Article
Open access
SPStefan Patauner
Stefan Patauner
GSGiovanni Scotton
Giovanni Scotton
FNFrancesca Notte
Francesca Notte
AFAntonio Frena
Antonio Frena
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide, with advanced stages posing significant treatment challenges. Although hepatic arterial infusion chemotherapy (HAIC) has emerged as a promising modality for treating advanced HCC, particularly in Asian clinical practice, its adoption in Western medicine remains limited due to a lack of large-scale randomized controlled trials. This editorial reviews and comments on the meta-analysis conducted by Zhou et al , which evaluates the efficacy and safety of HAIC and its combination strategies for advanced HCC. The authors performed a comprehensive meta-analysis of various clinical trials and cohort studies comparing HAIC and its combinations to other first-line treatments, such as sorafenib and transarterial chemoembolization (TACE). In this work, HAIC showed significantly better results regarding overall survival and progression-free survival compared to sorafenib or TACE alone and their combination. HAIC in combination with lenvatinib, ablation, programmed cell death 1 inhibitors, and radiotherapy further enhanced patient outcomes, indicating a synergistic effect. This editorial focuses on the critical role of multimodal treatment strategies in managing advanced HCC. It advocates for a paradigm shift towards integrated treatment approaches to enhance survival rates and improve the quality of life in patients with advanced HCC.

30 August 2022 in Journal of Medical Case Reports
Verified
Journal Article
Open access
PDF file
GBG. Bertelli
G. Bertelli
SPStefan Patauner
Stefan Patauner
TGT. Gorgatti
T. Gorgatti
AFAntonio Frena
Antonio Frena
Background: Right-side fixation of the sigmoid colon is a rare anatomical variant associated with intestinal malrotation (Choi et al. in J Korean Surg Soc. 84(4):256–60, 2013). Differently from other forms of malrotation, this variant has not been associated thus far with acute surgical conditions. Case presentation: In this report, we present a 65-year-old Caucasian patient admitted for bowel obstruction symptoms. Computed tomography scan revealed right-side fixation of the sigmoid colon extended to the subhepatic recess complicated by obstructed internal herniation of the ileum. In this patient, the sigmoid colon occupied a recess posterior to the ascending colon and right Toldt’s fascia. Within this narrow anatomical space, an ileal loop was trapped causing internal herniation with resultant close-bowel obstruction of both ileum and sigmoid colon. The ileal loop was released surgically and the anatomical abnormality corrected. Conclusions: To our knowledge, this is the first case of right-side fixation of the sigmoid colon causing acute obstruction secondary to internal herniation of the small intestine. Early recognition and precise anatomical definition of such anatomical variants are essential to optimize their surgical approach.